Cutter Incident

Cutter Incident. The Cutter Incident was a significant event in the history of public health and vaccine safety in the United States. Occurring in April 1955, it involved contaminated batches of the new Salk polio vaccine produced by Cutter Laboratories, which caused numerous cases of poliomyelitis. The tragedy led to a temporary halt of the national polio vaccination campaign and prompted major reforms in pharmaceutical manufacturing and government oversight.

Background and context

The mid-20th century was marked by intense fear of poliomyelitis, with frequent epidemics causing widespread paralysis and death. The breakthrough development of an inactivated vaccine by Jonas Salk at the University of Pittsburgh was met with national celebration. Following successful clinical trials overseen by the National Foundation for Infantile Paralysis, the vaccine was licensed for public use. The United States Department of Health, Education, and Welfare and the National Institutes of Health's Laboratory of Biologics Control were responsible for regulating production. Multiple pharmaceutical firms, including Cutter Laboratories in Berkeley, California, were contracted to manufacture the vaccine to meet massive public demand, initiating one of the largest public health campaigns in American history.

The incident

In April 1955, shortly after the national vaccination program began, reports emerged of vaccine-associated paralytic polio among recently inoculated children. The first cases were identified in Idaho and soon after in California, Illinois, and other states. Epidemiological investigations swiftly traced the source to specific lots of vaccine produced by Cutter Laboratories. It was determined that these lots contained live, virulent poliovirus that had not been fully inactivated during the manufacturing process. An estimated 120,000 doses of the defective vaccine had been administered before the campaign was suspended.

Immediate aftermath and response

The United States Public Health Service acted rapidly, recommending an immediate nationwide halt to all polio vaccination on April 27, 1955. This directive was issued by the Surgeon General of the United States, Leonard A. Scheele. Cutter Laboratories initiated a voluntary recall of its products. The consequences were severe: approximately 40,000 recipients developed abortive polio, 51 were permanently paralyzed, and five children died. The event caused a crisis of public confidence, sparked panic among parents, and led to numerous lawsuits against the manufacturer. The American Medical Association and state health departments worked to manage the clinical and communications crisis.

Investigation and findings

A thorough investigation was launched, involving the Laboratory of Biologics Control, an expert committee appointed by the Secretary of Health, Education, and Welfare Oveta Culp Hobby, and prominent virologists like Joseph Smadel. The Wyeth laboratory also discovered live virus in Cutter's products. The official inquiry, known as the Lennette Commission, concluded that Cutter Laboratories had followed the prescribed Salk protocol but that the method for inactivating the virus with formalin was inherently fragile and could allow live virus to survive if manufacturing conditions varied. The fault was found to lie both in the protocol's design and in inadequate regulatory testing and oversight by the National Institutes of Health.

Long-term impact and legacy

The Cutter Incident had a profound and lasting impact on vaccine regulation and pharmaceutical law in the United States. It directly led to the creation of a much stronger federal oversight system, culminating in the establishment of the Division of Biologics Standards within the National Institutes of Health. The event influenced the passage of legislation that strengthened the Public Health Service Act and paved the way for modern regulatory frameworks. It also accelerated the development and adoption of the safer oral polio vaccine developed by Albert Sabin. The incident remains a foundational case study in medical ethics, product liability, and the critical importance of robust vaccine safety surveillance, cited alongside other medical tragedies like the thalidomide scandal.

Category:1955 in the United States Category:Medical controversies Category:History of medicine in the United States Category:Disasters in California